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Summary 
To examine T  cell receptor (TCR) diversity involved in the memory response to a persistent 
human pathogen, we determined nucleotide sequences encoding TCR-cx and -/3 chains from 
HLA-B8-restricted, CD8 + cytotoxic T  cell clones specific for an immunodominant epitope 
(FLRGRAYGL) in Epstein-Barr virus (EBV) nuclear antigen 3. Herein, we show that identical 
TCR protein sequences are used by dones from each of four healthy unrelated virus carriers; 
a clone from a fifth varied conservatively  at only two residues.  This dominant selection  of c~ 
and/3 chain rearrangements suggests that a persistent viral infection can select for a highly focused 
memory response and indicates a strong bias in gene segment usage and recombination. A novel 
double-step semiquantitative polymerase chain reaction (PCR) procedure and direct sequencing 
of amplified TCR cDNA from fresh lymphocytes derived from three HLA-B8 individuals detected 
transcripts  specific for the conserved/3 chain in an EBV-seropositive  donor but not in two 
seronegative donors. This report describes an unprecedented degree of conservation in TCR selected 
in response to a natural persistent infection. 
T 
he TCR-c~//3 is a clonally distributed heterodimeric gly- 
coprotein that  interacts with  immunogenic peptides 
presented by class I or class II MHC molecules. TCR-c~ and 
-/3 chains are derived through the rearrangement of variable 
(TCRAV and TCRBV), diversity (TCRBD),  and joining 
(TCRAJ and TCRBJ) gene segments. These segments, in 
combination with N region diversity in the  junctional regions, 
provide the variation necessary to recognize the wide range 
ofpeptide/MHC combinations (1). The hypervariable com- 
plementarity determining region 3 (CDR3) spans thejunc- 
tiona! regions and can interact directly with peptide epitopes 
(2). Despite the vast potential diversity of the TCR reper- 
toire, receptors specific for certain epitopes preferentially use 
particular gene segments (3, 4) although several receptors 
specific for a given epitope usually exist, even within a single 
individual. The fine specificity pattern ofa TCR toward pep- 
tide/MHC varies with differences in TCR primary structure, 
particularly in the CDR3 hypervariable  region (5).  Thus, 
different receptors that recognize a particular peptide/MHC 
will vary in affinity and in antigenic crossreactivity. This sug- 
gests the possibility of in vivo selection of a particular TCR 
subset with optimal proliferative reactivity to pathogen and 
environmental antigens. 
The present study was designed to define the TCR diver- 
sity in a long-term persistent infection, where the opportu- 
nity for selection of T cell clones of maximal af~nity might 
be optimal. Epstein-Barr virus (EBV) is a 3~ herpesvirus that 
persists in humans as a latent infection of B cells under the 
control of class I-restricted CD8 + cytotoxic T lymphocytes 
(CTL) (6). Here, we report the TCR-c~ and -3 chain sequences 
of six CTL clones specific for an immunodominant HLA- 
B8-restricted epitope within EBV nuclear antigen (EBNA) 
3 (7). These clones, from five unrelated donors, show an un- 
precedented degree of conservation for a specific TCR het- 
erodimer. A degenerate primer complementary to transcripts 
encoding the conserved TCR-3 chain CDR3 region was used 
to monitor these EBV-specific CTL ex vivo. The conserved 
TCR-/3 chain could be detected in peripheral blood mono- 
nuclear cells (PBMC) from the EBV-seropositive,  but not 
from the two seronegative  HLA-B8 donors tested. 
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CTL Clones.  To generate  EBV-specific  CTL clones, PBMC from 
five healthy unrelated EBV seropositive  donors, IM (HLA A1,A11; 
BS,B51), LC (HLA A1,-; B8,B18), SC (HLA A1,A31; BS,B51), 
AS (HLA A1; B8), or DD (HLA A1,A3; B8,B40), were stimu- 
lated in vitro with autologous EBV-transformed  lymphoblastoid 
cell lines, and the activated  T cells  cloned in agarose (8). CTL clones 
specific for an immunodominant HLA-BS-restricted  epitope within 
EBNA 3 (FLKGRAYGL, residues 339-347; hereafter referred to 
as FLK) (7) were defined by CTL-CTL killing (9) in the presence 
of peptide or by their capacity to specifically  lyse autologous T cell 
blasts pulsed with exogenous peptide. 
Amplification of Rearranged TCRA and 7URB Sequences.  Poly 
A + RNA was extracted from 1-5  x  106 CTL using a QuickPrep 
Micro mKNA purification kit (Pharmacia Biotech AB, Uppsala, 
Sweden). First strand cDNA was synthesized from 500 ng of poly 
A § RNA in a 20 #1 volume using  10 pmol each of antisense 
TCRAC-(Cat;  5'-GTTGCTCCAGGCCACAGCACTG-Y)  and 
TCRBC-(Ca; 5'-TATCTGGAGTCATIGA~GGGCA-Y) gene 
specific primers, 200  U  of reverse transcriptase (MMLV RT 
KNaseH-, Superscript II; GIBCO BILL, Gaithersburg, MD) ac- 
cording to the reaction conditions recommended by the manufac- 
turer. After 60 min at 45~  10 #1 of H20 was added and the 
KNA template hydrolyzed  by the addition of 2 #16 N NaOH and 
incubation at 65~  for 30 min. The eDNA was subsequently neu- 
tralized by the addition of 2 #1 6 N acetic acid and excess primer 
removed using a QIAquick-spin  PCK purification  kit (Qiagen Inc., 
Chatsworth, CA). The eDNA was concentrated  by ethanol precipi- 
tation and 4 pmol of the anchor (5'P-CACGAATTCACTATCGAT- 
TCTGGAACCTTCAGAGG-NH33') was ligated to the 3' end of 
the eDNA in a 10 #1 reaction volume according to the conditions 
described by Troutt et al. (10). After anchor ligation, 50% of the 
eDNA was used as a template for PCR amplification  using 10 pmol 
each of a primer complementary to the anchor (5'-CCTCTGAAG- 
GTTCCAGAATCGATAG-Y) and nested TCRAC-(Co2; 5'-GTC- 
CATAGACCTCATGTCTAGCACAG-Y)  or TCRBC-(Cb2; 5'-ATT- 
CACCCACCAGCTCAGCTCCACG-Y)  gene-specific primers. 
Amplifications  were performed  in 50 #1 reaction volumes  consisting 
of 200 #M dNTPs and 2.5 U ofTaq polymerase  (Ampli Taq) using 
a GeneAmp  PCK 9600 system (all  from Perkin-Elmer  Cetus Corp., 
Norwalk, CT). Reaction mixtures were subjected to 35 cycles of 
amplification followed by a 5 min final extension at 72~  Each 
cycle included denaturation at 95~  for 20 s, annealing at 60~ 
for 40 s, and extension at 72~  for 40 s. PCK products were ex- 
cised from 2.5% (1/2 x Tris-buffered  EDTA) Nusieve GTG agarose 
gels (FMC BioProducts, Rockland, ME) and purified using B-aga- 
rase I (New England Biolabs, Inc., Beverly, MA). 
Nucleotide Sequencing.  Nucleotide sequence analysis of recov- 
ered DNA fragments was performed using a PRISM Ready Reac- 
tion DyeDeoxy  Terminator  Cycle  Sequencing  Kit and a 373A DNA 
sequencer (Applied Biosystems  Inc., Foster City, CA). The nucleo- 
tide sequences published in this report were also confirmed by di- 
rect PCK amplifications from  1st  strand eDNA using specific 
TCRAV and TCRBV family primers (11). 
Semiquantitative PeR Analysis of FLR-specific TCR-~ Gene Ex- 
Imssion in Fresh Lyraphocytes.  Total  KNA was extracted from 5 x 
106  PBMC derived from  EBV-seronegative donors  PP  (HLA 
A1,24; B8,14) and WH (HLA A1-; B8,57) and seropositive  donor 
LC using an RNagents total RNA isolation kit (Promega Corp., 
Madison, WI). First strand cDNA was synthesized from 2/~g of 
total RNA according to the abovementioned procedure. 200 ng 
of 1st strand cDNA was used as a template for PCK amplification 
using C~3 and a TCRBV6 family-specific  primer (5'-GGCCTG- 
AGGGATCCGTCTC-Y). The amplified  transcripts were resolved 
on 4% Nusieve GTG agarose gels and purified using B-agarase I 
as described  above. 10 ng of  this material was used for a subsequent 
round of PCP, using 5 pmol each of a TCRBV6 family-specific 
primer and either a degenerate  primer complementary  to the CDR3 
region of the conserved B chain (/SCDR3; 5'-GTACTGCTC(G,A)- 
TA(A,G,C,T)GC-Y) or Cb3 for use as a standard for the calcula- 
tion of the relative abundance of the product obtained with the 
TCRBV6-BCDR3 primer set. The amplification  schedule  was 94~ 
for 20 s, 60~  for 20 s, and 72~  for 20 s. Amplifications were 
performed in 25-/~1 reaction volumes and samples were removed 
after 5, 10, 15, 20, and 25 cycles.  The amplified  products were sepa- 
rated on a 4% agarose gel and transferred to nylon membranes 
(Hybond  N § ,  Amersham International,  Little Chalfort,  UK). 
Specific sequences were identified  by hybridization with 32p-labeled 
CB and TCRBV6 probes at a concentration of 1-5  x  106 cpm/ml 
in a mixture containing 6 x SSC, 5 x Denhardt's solution, 0.5% 
SDS, and 500 #g/ml herring sperm DNA. Hybridizations were 
carried out at 420C overnight. The membranes were washed using 
a protocol consisting sequentially of two washes with 2  x  SSC, 
0.1% SDS and two washes  with 0.1 x SSC, 0.1% SDS. All washes 
were performed at 42~  Specific  DNA sequences were visualized 
by autoradiography  using Kodak  XAR-films.  Relative  quantification 
of the amplified  products was performed using a Computing Den- 
sitometer and ImageQuant software Version 3.3 (Molecular Dy- 
namics, Inc., Sunnyvale, CA). 
Results and Discussion 
TCRA(V-J-C) and TCRB(V-D-J-C) rearrangements ex- 
pressed  by FLK-specific CTL clones from IM  (IM6),  SC 
(SC17),  AS  (AS1 and AS7),  LC (LC13),  and DD  (DD1) 
were identified using  a  modification of the  single  strand 
ligation to single-stranded eDNA technique (10, 12) (Fig. 
1;  see reference  13 for nomenclature). All clones expressed 
TCRAV4S1J14S3 (Fig. 1 A) and TCR.BV6S3*aJ2S7 (Fig. 1 B). 
Comparison of these sequences with known or interpreted 
germline V  and J  segment sequences  (13-16)  showed that 
the cz chain junctional CDK3 regions of IM6, SC17, AS1, 
AS7,  and LC13 encoded identical proteins and that codon 
usage varied only in N  regions. Analysis of nucleotide se- 
quences  encoding the/3 chain CDR3 regions showed that 
clones IM6, SC17, and AS1 arrived  at the same junctional 
sequence by loss of nucleotides from TCRBD1. The glycine 
codons in clones AS7 and LC13 were formed either by a por- 
tion of TCRBD2 rearranged to TCRBD1 or by N  region 
addition. These clones have the same c~ and ~ chains gener- 
ated by different rearrangement events. The junctional regions 
of the c~ and B chains of done DD1 were encoded mostly 
by N  region additions and differed from the other five by 
a single amino acid change in the CDR3 region of each chain: 
c~110 (Ala ~  Ser) and Bl15  (Leu ~  Ile)  (Fig.  1). 
To determine how these differences related to target rec- 
ognition, the fine specificity of FLK-specific CTL clones LC13, 
IM6, and DD1 was determined by using a replacement set 
of peptides in which each residue within FLK was sequen- 
tiaUy replaced with all other genetically coded amino acids 
(7). The three clones had identical reactivity patterns (data 
not shown), except that DD1 did not tolerate the substitu- 
tion of serine for glycine at position 8 (P8) of the parent pep- 
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Figure  1.  Sequence  analysis of~ICR 
variable  regions.  The nucleotide  se- 
quences are presented, and the one-letter 
code designating the transhted amino 
acid is shown above the first nudeotide 
in each codon: (A) a  chain sequences; 
(B) ~ chain sequences.  The borders be- 
tween  TCR  V,  N,  (D+N),  and  J 
regions are based on known or inter- 
preted germline sequences  (13-16) and 
are  shown  by  gaps  in  the  sequence. 
Framework cysteines are numbered ac- 
cording to published TCRAV4S1  and 
TCRBV6S3*a  (13) deduced amino acid 
sequenc~ TCRBD-matching  sequences 
are undertinea~ These ~/~ chain sequence 
data  are  available  from  EMBL/Gen- 
Bank/DDBJ under accession numbers 
L26453/L26454  (IM6); L26457/L26458 
(SC17); L29035/L29037  (AS1); L29036/ 
L29038 (AS7); L26455/L26456  (LC13); 
and L26451/L26452  (DD1), respectively. 
tide. The conservative changes in the TCR sequence of clone 
DD1  may account for  the intolerance  of this clone to  the 
P8 (Gly --~  Ser) substitution in the replacement  analysis. 
We took advantage  of the conserved FLR-specific TCR-cff~/ 
heterodimer  to synthesize a degenerate primer complemen- 
tary to the TCRB CDR3 region, to monitor the FLR-specific 
CTL ex vivo. Fresh PBMC were isolated from one HLA-B8 
EBV-seropositive (LC) and two HLA-B8 seronegative donors 
(PP and WH). A double-step PCR was performed in which 
all TCRBV6 sequences were amplified in the first step. Semi- 
quantitative  PCR was employed in the second step using a 
TCRBV6 family primer (TCRBV6) and a degenerate primer 
complementary  to  the 3' end of the CDR3  region of the 
conserved  FLR-specific  TCRB gene (BcnR3) coding for the 
amino add sequence QAYEQY (degenerate codon specification 
underlined). Total TCRBV6 sequences  were coamplified  as 
a standard for the calculation of the relative abundance  of 
the product obtained  with the TCRBV6-BcoR3  primer set. 
Comparison of the normalized PCR profiles using a com- 
puting densitometer revealed that a DNA band with the ex- 
pected  mobility of an amplified product encoding the con- 
served TCR-/3 chain could be detected in the EBV-seropositive 
donor (LC) at levels at least 25-fold above those of the seronega- 
tive donors  (Fig.  2).  Similar  results  were obtained  with a 
BcDvJ primer coding for the CDR3 sequence GQAYE (data 
not shown).  Further  extensions of the/~r  primer  were 
not used because  of the high level  of degeneracy  (12  x  4 
x  2  x  4 for I/L  x  G  x  Q  x  A)involved. Direct sequencing 
of the PCR products  showed that only one nucleotide se- 
quence was amplified from donor LC, identical to that found 
in the CTL clone LC13  (Fig.  1).  This is in accord with a 
preliminary  study to this report  in which 17 FLR-specific 
CTL clones from donor LC, derived from three separate ex- 
periments using different  stimulation protocols,  coded for 
identical TCRB nucleotide  sequences (our unpublished data). 
Further  amplification  (35  cycles)  of  the  TCRBV6-~cD~s 
products from the EBV-seronegative  donors PP and WH al- 
lowed direct sequencing of the corresponding bands. In nei- 
ther case was a coherent sequence derived for the N-(D)-N 
region.  A  coherent  sequence  was obtained downstream of 
this region from donor WH, but not from donor PP, indi- 
cating a dominant CDR3 length component in the amplified 
product, one amino acid longer than the conserved/3 chain. 
The  high level  of specific  product  amplified  in  the EBV- 
seropositive  donor is consistent with the high precursor fre- 
quency  (up  to  1/2,000;  Burrows,  S.  R.,  D.  J.  Moss,  R. 
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Figure  2.  Semiqnantitative  analysis 
of the conserved  FLR-specific/~ chain 
in  HLA-B8 §  donors  PP,  WH,  and 
LC. (.4) Amplification of total TCRBV6 
sequences.  (B)  Amplification  of con- 
served FLR-specific ~ chain. Reactions 
were terminated  at the completion of 
5, 10, 15, 20, and 25 qr.les. (-)denotes 
control  reactions  excluding  template 
that were terminated after 25 cycles of 
amplification. Khanna, I. S. Misko, and V. P. Argaet, manuscript in prepa- 
ration)  of FLR-specific CTL in HLA-B8 donors,  and pro- 
vides strong evidence that these clones are reflective of the 
circulating CTL population.  The detection of the particular 
/5 chain employed by FLR-specific CTL in PBL from an EBV- 
seropositive donor, but not in two seronegative donors pro- 
vides an exciting possibility of using PCR to directly mon- 
itor FLR-specific CTL in individuals during primary infec- 
tion or after vaccination with the peptide  FLR. 
This report describes an unprecedented degree of conser- 
vation in TCR selected in response to a natural persistent 
infection. We interpret these results in a model that invokes 
restriction on the TCR repertoire not only (a) at the protein 
level, shaped by positive and negative selection in the thymus 
and by events occurring in the periphery as a result of chronic 
immune stimulation,  but also, (b) at the nucleic acid level 
before thymic selection as indicated by the remarkable bias 
among unrelated individuals toward identical dominant TCR 
rearrangements. 
Peripheral restimulation of CTL is thought to maintain 
a life-long potent memory T cell compartment, a feature of 
healthy virus carriers. In a persistent infection, dominant CTL 
clones could arise from their preferential restimnlation due 
to higher affinity antigen receptors. Thus, EBV-specific  CTL 
with a high affinity TCR could respond to marginal antigen 
concentrations  on infected B cells, an important advantage 
post convalescence  when antigen is presumably limiting. Our 
strategy does not address the issue of whether any or all of 
the defined TCR components are essential to FLR reactivity, 
in contrast to the demonstration that certain V/5 chains are 
obligate in some murine responses (17). Instead, we postu- 
late that the TCR amino acid sequences defined here have 
a high affinity for FLIk/HLA-B8, and that clones expressing 
these receptors have asserted their dominance, according to 
the balance of growth model (18), over lower affinity FLR- 
specific clones that may have been stimulated during the pri- 
mary response. Indeed, the two FLR-specific  CTL clones from 
donor AS coded for identical TCR-ot/B heterodimers but 
were generated by different rearrangement events as evidenced 
by the use of  different N-(D)-N regions in both chains. These 
data strongly suggest that this TCR heterodimer combina- 
tion is preferentially selected for interacting with FLR/HLA- 
B8. Selection has been shown in vitro since repeated stimula- 
tion of T cell lines by antigen can lead to selection of certain 
clonotypes (19). Moreover, recent evidence suggests that a 
chronic infection with human immunodeficiency virus 1 can 
sustain selectively  expanded envelope-specific  CTL clones that 
express a limited TCR repertoire  (20). Chronic restimula- 
tion of T cells also presumably occurs in autoimmune dis- 
orders where T cell responses have been shown to be either 
oligodonal or polyclonal (17, 21). 
We have recently shown that CTL (such as those exam- 
ined here) from B'4402-  donors specific for FLR/HLA-B8 
recognize non-EBV-infected cells from HLA-B*4402 donors, 
presumably through a self-peptide in association with that 
allele (22). In a subsequent study to the one presented here, 
we have shown that CTL recognizing FLR/HLA-B8 can 
be raised from EBV seropositive HLA-B*4402 donors, but 
these do not employ the same TCR sequences described in 
this report (Burrows et al., manuscript in preparation). These 
data indicate that the conserved TCR heterodimer defined 
herein has not dominated simply because it is the only ol/3 
combination capable to recognizing FLR/HLA-B8 due, for 
example, to structural  constraints  (23). 
Our results differ with other studies that have shown vari- 
able CDK3 regions or the usage of different tx or B chain 
rearrangements  in T cells recognizing specific epitopes de- 
rived from nonpersisting antigens (4). For instance, the human 
TCK repertoire against defined influenza nuclear protein epi- 
topes has been shown to be oligoclonal (23). Moreover, TCR 
repertoires in mice are often examined in the short-term and 
in response to high challenge doses of antigen (4). The former 
precludes selection by chronic restimulation, while the latter 
may encourage the growth of  clones of  lesser affinity. In terms 
of the EBV model, such protocols are more likely to be rele- 
vant to the primary response seen in acute infectious mono- 
nucleosis, where a range of TCR may respond to the same 
epitope. Indeed,  a longitudinal study is in progress that is 
designed to  monitor the FLK-specific TCR repertoire  in 
HLA-B8 donors from an acute to a persistent phase of the 
disease. 
Estimates of the potential TCK-,v/B repertoire range from 
10  is  to  1020 based  on  random employment of N  region 
nucleotides and V, D andJ elements (24, 25). Since the adult 
human has m 1012 lymphocytes, the finding of clones with 
identical TCK in unrelated individuals must also involve a 
bias in gene segment rearrangement. Contributions to bias 
at this level have been demonstrated by nonrandomness  in 
V-J pairing, N region addition and CDR3 region length (26). 
Also, the expression of a rearranged/5 chain before tx chain 
rearrangement may allow a process of "/5 selection" (27) to 
favor the survival of certain B chain sequences. We further 
note that the five clones expressing identical TCIk are almost 
exclusively germline encoded in the B chain CDR3 region 
indicating that these may be especially  favored  rearrangements. 
TCRBV6S3 and TCRBJ2S7 gene segments have been shown 
to be particularly common in adult peripheral blood (28, 29) 
and based on these data, the TCRBV6S3J2S7 rearrangements 
may account for up to 4% of/5 chains. As there are poten- 
tially 5  x  107 different ot chains (24), the finding of iden- 
tical TCRAV  sequences in several individuals also strongly 
suggests a bias in tx chain rearrangement. 
EBV is ubiquitous  and related ~ herpesviruses are found 
in all old-world primate species (30). Moreover, infection is 
common prior to the onset of sexual maturity and is poten- 
tially fatal in individuals with a defective CTL response who 
are typically at higher risk of developing lymphoblastoid cell 
line-like lymphomas. We favor, therefore, that a bias in the 
production of specific  TCR rearrangements has coevolved  with 
EBV and the MHC to facilitate a balanced virus-host  rela- 
tionship. 
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